Veramed, a company that provides Statistics and Programming FSP and Consultancy services to Pharmaceutical and Biotech clients, has named Stuart McGuire as its new chief business officer, it was reported yesterday.

The company said that in the new role, McGuire will head the development of the business as it evolves its position as the pharmaceutical industry's preferred statistics and programming CRO partner.

McGuire joins Veramed from Covance (formerly Chiltern International), where he held senior positions across business development, leadership and alliance partnerships, and will concentrate on building Veramed relationships across Europe, North America and Japan.